Mel number | Sex | Successful expansion (N = 29) | Tumor-reactive (N = 21) | FFPE (N = 17) | Site | Time to growth (days) |
---|---|---|---|---|---|---|
Mel-119 | M | No | Â | Â | Right Groin | Â |
Mel-120 | F | No | Â | Â | Â | Â |
Mel-131 | M | Yes | Yes | Â | Right Back | 29 |
Mel-133 | M | Yes | Yes | FFPE | Liver | 30 |
Mel-134 | M | Yes | Yes | Â | Â | 38 |
Mel-135 | F | No | Â | FFPE | Right supraclavicular mass | Â |
Mel-140 | F | Yes | No | Â | Â | 37 |
Mel-144 | M | No | Â | FFPE | Intraperitoneal mass | Â |
Mel-145 | M | Yes | Yes | Â | Â | 27 |
Mel-150 | F | No | Â | Â | Right back mass | Â |
Mel-160 | F | Yes | Yes | FFPE | Right Thigh | 26 |
Mel-163 A | F | Yes | Yes | FFPE | Illiac LN | 55 |
Mel-173-C | 5Â F | Yes | Yes | FSC | Â | 40 |
Mel-176 | M | Yes | Yes | FFPE | lower left lobe | 34 |
Mel-177A | F | Yes | Yes | FSC | Right Leg mass | 25 |
Mel-179 | F | Yes | No | FSC | Right axillary mass | 56 |
Mel-180A | M | Yes | Yes | Â | Axillary tumor mass | 40 |
Mel-181 | F | Yes | Yes | Â | Â | 12 |
Mel-182 | M | No | Â | FFPE | Left pelvic mass | Â |
Mel-185 | M | Yes | Yes | FSC | Superior medistinal mass | 33 |
Mel-186 | M | No | Â | FSC | Right lower lobe mass | Â |
Mel-187 | M | Yes | No | Â | Paracenthesis fluid | 67 |
Mel-188 | M | Yes | No | FFPE | Right Axillary LN | 41 |
Mel-189 | M | No | Â | Â | Left Chest wall | Â |
Mel-189A | M | Yes | Yes | Â | Â | 32 |
Mel-190 | M | No | Â | FFPE | Small Bowl | Â |
Mel-191 | M | Yes | No | Â | LN | 28 |
Mel-192 | F | No | Â | Â | Thigh | Â |
Mel-193 | F | No | Â | Â | Left Lung Upper Lobe | Â |
Mel-199 | M | Yes | Yes | FSC | Â | 48 |
Mel-200 | M | Yes | Yes | FSC | Left lower tumor | 37 |
Mel-201 | M | Yes | Yes | Â | Â | 26 |
Mel-206 | M | Yes | Yes | Â | Â | 56 |
Mel-207 | M | Yes | Yes | Â | Â | 35 |
Mel-208 | M | Yes | Yes | Â | Left lower lobe LN | 33 |
Mel-209 | M | Yes | Yes | FFPE | Liver mass | 29 |
Mel-211 | F | Yes | Yes | Â | Liver mass | 26 |